首页> 外文会议>Biomedical Applications of Raman Spectroscopy >Raman SERS and induced circular dichroism techniques as a probe of pharmaceuticals in their interactions with the human serum albumin and p-glycoprotein
【24h】

Raman SERS and induced circular dichroism techniques as a probe of pharmaceuticals in their interactions with the human serum albumin and p-glycoprotein

机译:拉曼SERS和诱导圆二色性技术作为药物与人血清白蛋白和p-糖蛋白相互作用的探针

获取原文
获取原文并翻译 | 示例

摘要

Abstract: Camptothecin (CPT) derivatives are the well known inhibitors of the human DNA topoisomerase (topo) I. Two of them, irinotecan and topotecan, are just in the clinics; 9-amino- CPT is on the stage II of clinical trials, and the active search for new derivatives is now in progress. Stability of the CPT derivatives on their way to the target and resistance of cancer cells to these drugs present the crucial problem of the chemotherapy. Human serum albumin (HSA) is the mediator of transport and metabolism of numerous pharmaceuticals in the blood and P-glycoprotein (P- gp) plays a crucial role of the mediator of the multidrug resistance (MDR) of the cancer cells. This paper present the result of analysis of molecular interactions of some drugs of CPT family with the HSA and P-gp. Induced circular dichroism (CD) and Raman techniques have been applied for monitoring molecular interaction of drugs with HSA as well as to identify the conformational transition of the protein induced by the drug binding. Drug molecular determinants responsible for interaction have been identified and their binding sites within the HSA have been localized. New cancer cells lines exhibiting an extremely high level of MDR resistance have been established and were shown to contain the P-gp overproduced in the quantities of 35 percent from the all membrane proteins. The membrane fractions of these cells with the controls presented by the membranes of the parental membrane proteins. The membrane fractions of these cells with the controls presented by the membranes of the parental sensitive cells may be used as a model system for spectroscopic analysis of the specific pharmaceuticals/P-gp interactions. !16
机译:摘要:喜树碱(CPT)衍生物是人类DNA拓扑异构酶(topo)I的众所周知的抑制剂。伊立替康和托泊替康这两种药物正处于临床中。 9-氨基-CPT正在临床试验的第二阶段,并且正在积极寻找新的衍生物。 CPT衍生物到达靶标途中的稳定性以及癌细胞对这些药物的耐药性是化疗的关键问题。人血清白蛋白(HSA)是血液中多种药物的运输和代谢的介质,P-糖蛋白(P-gp)在癌细胞的多药耐药性(MDR)的介质中起着至关重要的作用。本文介绍了一些CPT家族药物与HSA和P-gp的分子相互作用的分析结果。诱导圆二色性(CD)和拉曼技术已用于监测药物与HSA的分子相互作用以及鉴定由药物结合诱导的蛋白质的构象转变。已经确定了负责相互作用的药物分子决定簇,并且它们在HSA中的结合位点已经定位。已经建立了表现出极高水平的MDR抗性的新癌细胞系,并显示它们含有从所有膜蛋白中过量生产的35%的P-gp。这些细胞的膜级分具有由亲代膜蛋白的膜呈现的对照。这些细胞的膜级分具有亲本敏感细胞的膜呈现的对照,可以用作用于特定药物/ P-gp相互作用的光谱分析的模型系统。 !16

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号